Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saver, J. L.
Right arrow Articles by Haley, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saver, J. L.
Right arrow Articles by Haley, E. C.
Related Collections
Right arrow Health policy and outcome research
Right arrow Acute Cerebral Infarction
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Epidemiology

(Stroke. 1999;30:293-298.)
© 1999 American Heart Association, Inc.


Original Contributions

Infarct Volume as a Surrogate or Auxiliary Outcome Measure in Ischemic Stroke Clinical Trials

Presented in part at the 121st Annual Meeting of the American Neurological Association, Miami, Fla, October 13–16, 1996.

Jeffrey L. Saver, MD; Karen C. Johnston, MD; Daniel Homer, MD; Robert Wityk, MD; Walter Koroshetz, MD; Laura L. Truskowski, PhD; E. Clarke Haley, MD for the RANTTAS Investigators

From the Stroke Center and Department of Neurology, University of California, Los Angeles (J.L.S.); the Department of Neurology, University of Virginia (Charlottesville) (K.C.J., L.L.T., E.C.H.); the Department of Neurology, Northwestern Medical School, Evanston, Ill (D.H.); the Department of Neurology, Johns Hopkins University, Baltimore, MD (R.W.); and the Department of Neurology, Harvard Medical School, Boston, Mass (W.K.).

Correspondence to Jeffrey L. Saver, MD, UCLA Stroke Center, Reed Neurologic Research Center, 710 Westwood Plaza, Los Angeles, CA 90095. E-mail jsaver{at}ucla.edu

Background and Purpose—Reduction in infarct volume is the standard measure of therapeutic success in animal stroke models. Reduction in infarct volume has been advocated as a biological surrogate or auxiliary outcome measure for human stroke clinical trials to replace or supplement deficit, disability, and global clinical scales. However, few studies have investigated correlations between infarct volume and clinical end points in acute ischemic stroke patients.

Methods—CT scans at days 6 to 11 were acquired prospectively in 191 fully eligible patients enrolled in the Randomized Trial of Tirilazad Mesylate in Patients With Acute Stroke (RANTTAS). Patients were enrolled within 6 hours of onset of stroke in any vessel distribution. Infarct volume was measured by operator-assisted computerized planimetry.

Results—One hundred thirty-two patients had visible new supratentorial infarcts, with median infarct volume of 28.0 cm3 (interquartile range, 9.0 to 93.0 cm3). Fifty-nine patients had no visible new infarct. Correlations with standard 3-month outcome scales and mortality were as follows: Barthel Index, r=0.43; Glasgow Outcome Scale, r=0.53; National Institutes of Health Stroke Scale, r=0.54; mortality, r=0.31. For visible infarcts alone, correlations were as follows: BI, r=0.46; GOS, r=0.59; NIHSS, r=0.56; mortality, r=0.32.

Conclusions—Subacute CT infarct volume correlates moderately with 3-month clinical outcome as assessed by widely used neurological and functional assessment scales. The modesty of this linkage constrains the use of infarct volume as a surrogate end point in ischemic stroke clinical trials.


Key Words: cerebral infarction • clinical trials • stroke assessment • stroke outcome • tomography, x-ray computed




This article has been cited by other articles:


Home page
NeurologyHome page
J. R. Sims, L. R. Gharai, P. W. Schaefer, M. Vangel, E. S. Rosenthal, M. H. Lev, and L. H. Schwamm
ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes
Neurology, June 16, 2009; 72(24): 2104 - 2110.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. S. Kidwell, K. R. Lees, K. W. Muir, C. Chen, S. M. Davis, D. A. De Silva, C. J. Weir, S. Starkman, J. R. Alger, J. L. Saver, et al.
Results of the MRI Substudy of the Intravenous Magnesium Efficacy in Stroke Trial
Stroke, May 1, 2009; 40(5): 1704 - 1709.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. C. Johnston, K. M. Barrett, Y. H. Ding, D. P. Wagner, and for the ASAP Investigators
Clinical and Imaging Data at 5 Days as a Surrogate for 90-Day Outcome in Ischemic Stroke
Stroke, April 1, 2009; 40(4): 1332 - 1333.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Whitehead, K. Bolland, E. Valdes-Marquez, A. Lihic, M. Ali, K. Lees, and for the VISTA Collaborators
Using Historical Lesion Volume Data in the Design of a New Phase II Clinical Trial in Acute Stroke
Stroke, April 1, 2009; 40(4): 1347 - 1352.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
B. H. Buck, D. S. Liebeskind, J. L. Saver, O. Y. Bang, S. Starkman, L. K. Ali, D. Kim, J. P. Villablanca, N. Salamon, S. W. Yun, et al.
Association of Higher Serum Calcium Levels With Smaller Infarct Volumes in Acute Ischemic Stroke
Arch Neurol, September 1, 2007; 64(9): 1287 - 1291.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. L. Saver
Time Is Brain--Quantified
Stroke, January 1, 2006; 37(1): 263 - 266.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
S. K. Schiemanck, M. W.M. Post, Th. D. Witkamp, L. J. Kappelle, and A. J.H. Prevo
Relationship between Ischemic Lesion Volume and Functional Status in the 2nd Week after Middle Cerebral Artery Stroke
Neurorehabil Neural Repair, June 1, 2005; 19(2): 133 - 138.
[Abstract] [PDF]


Home page
StrokeHome page
J. J. Kim, N. J. Fischbein, Y. Lu, D. Pham, and W. P. Dillon
Regional Angiographic Grading System for Collateral Flow: Correlation With Cerebral Infarction in Patients With Middle Cerebral Artery Occlusion
Stroke, June 1, 2004; 35(6): 1340 - 1344.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. D. Lindner, V. K. Gribkoff, N. A. Donlan, and T. A. Jones
Long-Lasting Functional Disabilities in Middle-Aged Rats with Small Cerebral Infarcts
J. Neurosci., November 26, 2003; 23(34): 10913 - 10922.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. R. Crafton, A. N. Mark, and S. C. Cramer
Improved understanding of cortical injury by incorporating measures of functional anatomy
Brain, July 1, 2003; 126(7): 1650 - 1659.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J M Wardlaw, T M West, P A G Sandercock, S C Lewis, and O Mielke
Visible infarction on computed tomography is an independent predictor of poor functional outcome after stroke, and not of haemorrhagic transformation
J. Neurol. Neurosurg. Psychiatry, April 1, 2003; 74(4): 452 - 458.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. P. Adams Jr, R. J. Adams, T. Brott, G. J. del Zoppo, A. Furlan, L. B. Goldstein, R. L. Grubb, R. Higashida, C. Kidwell, T. G. Kwiatkowski, et al.
Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association
Stroke, April 1, 2003; 34(4): 1056 - 1083.
[Full Text] [PDF]


Home page
Arch NeurolHome page
S.-H. Oh, J.-G. Lee, S.-J. Na, J.-H. Park, Y.-C. Choi, and W.-J. Kim
Prediction of Early Clinical Severity and Extent of Neuronal Damage in Anterior-Circulation Infarction Using the Initial Serum Neuron-Specific Enolase Level
Arch Neurol, January 1, 2003; 60(1): 37 - 41.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
V. S. Caviness, N. Makris, E. Montinaro, N. T. Sahin, J. F. Bates, L. Schwamm, D. Caplan, and D. N. Kennedy
Anatomy of Stroke, Part II: Volumetric Characteristics With Implications for the Local Architecture of the Cerebral Perfusion System
Stroke, November 1, 2002; 33(11): 2557 - 2564.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. Z. Simonsen, L. Rohl, P. Vestergaard-Poulsen, C. Gyldensted, G. Andersen, and L. Ostergaard
Final Infarct Size after Acute Stroke: Prediction with Flow Heterogeneity
Radiology, October 1, 2002; 225(1): 269 - 275.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. C. Roberts, W. P. Dillon, A. J. Furlan, L. R. Wechsler, H. A. Rowley, N. J. Fischbein, R. T. Higashida, C. Kase, G. A. Schulz, Y. Lu, et al.
Computed Tomographic Findings in Patients Undergoing Intra-arterial Thrombolysis for Acute Ischemic Stroke due to Middle Cerebral Artery Occlusion: Results From the PROACT II Trial * Editorial Comment: Results From the PROACT II Trial
Stroke, June 1, 2002; 33(6): 1557 - 1565.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. C. Johnston, D. P. Wagner, E. C. Haley Jr, and A. F. Connors Jr
Combined Clinical and Imaging Information as an Early Stroke Outcome Measure
Stroke, February 1, 2002; 33(2): 466 - 472.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. B. van der Worp, L. J. Kappelle, A. Algra, P. R. Bar, J. M. Orgogozo, E. B. Ringelstein, P. M.W. Bath, and J. van Gijn
The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke
Neurology, January 8, 2002; 58(1): 133 - 135.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Kissela, J. Broderick, D. Woo, R. Kothari, R. Miller, J. Khoury, T. Brott, A. Pancioli, E. Jauch, J. Gebel, et al.
Greater Cincinnati/Northern Kentucky Stroke Study : Volume of First-Ever Ischemic Stroke Among Blacks in a Population-Based Study Editorial Comment : The Greater Cincinnati/Northern Kentucky Stroke Study: Volume of First-Ever Ischemic Stroke Among Black Americans in a Population-Based Study
Stroke, June 1, 2001; 32(6): 1285 - 1290.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. G. Lansberg, M. W. O'Brien, D. C. Tong, M. E. Moseley, and G. W. Albers
Evolution of Cerebral Infarct Volume Assessed by Diffusion-Weighted Magnetic Resonance Imaging
Arch Neurol, April 1, 2001; 58(4): 613 - 617.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. B. van der Worp, S. P. Claus, P. R. Bar, L. M. P. Ramos, A. Algra, J. van Gijn, and L. J. Kappelle
Reproducibility of Measurements of Cerebral Infarct Volume on CT Scans
Stroke, February 1, 2001; 32(2): 424 - 430.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
NINDS
Effect of Intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography
Stroke, December 1, 2000; 31(12): 2912 - 2919.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
V. N. Thijs, M. G. Lansberg, C. Beaulieu, M. P. Marks, M. E. Moseley, and G. W. Albers
Is Early Ischemic Lesion Volume on Diffusion-Weighted Imaging an Independent Predictor of Stroke Outcome? : A Multivariable Analysis
Stroke, November 1, 2000; 31(11): 2597 - 2602.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Tirilazad Mesylate in Acute Ischemic Stroke : A Systematic Review
Stroke, September 1, 2000; 31(9): 2257 - 2265.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
P James, C J Ellis, R M L Whitlock, A R McNeil, J Henley, and N E Anderson
Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study
BMJ, June 3, 2000; 320(7248): 1502 - 1504.
[Abstract] [Full Text]


Home page
StrokeHome page
R. Pineiro, S. T. Pendlebury, S. Smith, D. Flitney, A. M. Blamire, P. Styles, and P. M. Matthews
Relating MRI Changes to Motor Deficit After Ischemic Stroke by Segmentation of Functional Motor Pathways
Stroke, March 1, 2000; 31(3): 672 - 679.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. C. Johnston, A. F. Connors Jr, D. P. Wagner, W. A. Knaus, X.-Q. Wang, and E. C. Haley Jr
A Predictive Risk Model for Outcomes of Ischemic Stroke
Stroke, February 1, 2000; 31(2): 448 - 455.
[Abstract] [Full Text] [PDF]